Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986–2019 - O'Neill : O'Neill

PLOS Medicine | November 16, 2023

Read the Publication

Latest publications See All

Op-Ed

April 25, 2025

ACA’s Preventive Services Mandate: What’s at Stake?

Op-Ed

April 25, 2025

Commentary: US needs holistic approach to curb overdose deaths

Report

April 24, 2025

Supreme Court Hears Argument Over Fate Of Preventive Services Under ACA